ChemAxon said this week that Boehringer Ingelheim will use its cheminformatics platform to store, search, and visualize chemical entities, properties, and reactions as part of its internal and external drug research and development efforts.
ChemAxon said that Boehringer chose its software after evaluating factors such as its return on investment, performance, robustness, and scalability.
Other pharmaceutical companies that use ChemAxon's software include Japan's Eisai, which licensed its JChem Cartridge database management and search tool (BI 1/6/2012); and Pfizer, which licensed its platform to help with Markush structure searching (BI 1/22/2010).